Inhibition of the renin-angiotensin system in severe COPD

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 1130-

  Mascitelli, L ^a   Pezzetta, F ^b   Goldstein, M R ^c  

^a Medical Service   (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

^c Fountain Medical Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN;

ANTIINFLAMMATORY ACTIVITY; ASPIRATION PNEUMONIA; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ERYTHROCYTOSIS; ERYTHROPOIESIS; HUMAN; HYPOXIA; INFLAMMATION; LETTER; LUNG; MUSCLE FUNCTION; POLYCYTHEMIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANOXIA; HUMANS; INFLAMMATION; LUNG; MUSCLES; PEPTIDYL-DIPEPTIDASE A; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME;

EID: 58849089210     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00082308     Document Type: Letter

References (10)

1. Albert P, Calverley PMA. Drugs (including oxygen) in severe COPD. Eur Respir J 2008; 31: 1114-1124.
2. Nong Z, Stassen JM, Moons L, Collen D, Janssens S. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling. Circulation 1996; 94: 1941-1947.
3. Kanazawa H, Okamoto T, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1235-1238.
4. Kanazawa H, Hirata K, Yashikawa J. Effects of captopril administration on pulmonary hemodynamics and tissue oxygenation during exercise in ACE gene subtypes in COPD patients: a preliminary study. Thorax 2003; 58: 629-631.
5. Cazzola M, Matera MG, Rogliani P, Page C. Treating systemic effects of COPD. Trends Pharmacol Sci 2007; 28: 544-550.
6. Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens 2007; 21: 20-27.
7. Mrug M, Stoppa T, Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997; 100: 2310-2314.
8. Julian BA, Brantley RR Jr, Barker CV, et al. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. J Am Soc Nephrol 1998; 9: 1104-1108.
9. Plata R, Cornejo A, Arratia C, et al. Angiotensin-converting- enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial. Lancet 2002; 359: 663-666.
10. Rafailidis PI, Matthaiou DK, Varbobitis I, Falagas ME. Use of ACE inhibitors and risk of community-acquired pneumonia: a review. Eur J Clin Pharmacol 2008; 64: 565-573.